(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back ...

Pain comes in many forms, and Abbott aims to treat as many as it can with its devices. The company received a new approval from the FDA for its low-dose spinal cord stimulator implant, covering ...

The new indication for Abbott's Proclaim™ XR SCS system provides a non-medication option for people with painful diabetic peripheral neuropathy Spinal cord stimulation is proven to be more ...

The U.S. Food and Drug Administration (FDA) approved Abbott's Eterna™ spinal cord stimulation (SCS) system for the treatment of chronic painThis neuromodulation device provides an optimized ...